andrew armstrong, md, provides insight as to genetic testing to be conducted in a patient with mpc
Published 4 years ago • 36 plays • Length 1:29Download video MP4
Download video MP3
Similar videos
-
1:05
andrew armstrong, md, explains whether arv-7 is predictive of response to taxanes in mpc patients
-
2:09
andrew armstrong, md, on determining treatment of prostate cancer with dna repair markers
-
4:51
ambry genetics: genetic testing in the field
-
9:53
dr. andrew armstrong on precision medicine approaches in advanced prostate cancer
-
56:21
genetic testing for prostate cancer: advances and considerations | webinar | ambry genetics
-
19:56
genetic testing for diagnosis (bruce gelb, md)
-
38:48
international perspectives on genetic testing in als
-
2:05
what is genetic testing for mds?
-
33:45
genetic testing in adult neurology patients | webinar | ambry genetics
-
4:00
genetic testing in aml: what are doctors looking for?
-
5:04
genetic testing and disease
-
9:02
what is genetic testing for cancer? all about precision cancer diagnostics
-
1:48
understanding genetic testing, its benefits and who should consider getting it
-
1:24
andrew armstrong, md, offers opinion on androgen receptor inhibitors
-
7:21
future of genetic testing and treatment in prostate cancer
-
23:38
genetic testing in advanced prostate cancer
-
2:09
the importance of genetic testing for patients with apc
-
57:48
the role of genetics and amd
-
9:21
researchers aim unlock genetic data goldmine